Remifentanil clinical use includes which of the following procedures?

Remifentanil clinical use includes which of the following procedures?

• A. Retrobulbar blocks, laryngoscopy, and procedures requiring transient profound analgesia
• B. Chronic cancer pain management
• C. Oral analgesia
• D. Long-term postoperative analgesia

Answer: (A)

Remifentanil is an ultra-short-acting opioid that is rapidly metabolized by plasma esterases, giving a very quick onset and a context-insensitive half-life of only a few minutes. This means its analgesic effects (and any sedation) disappear almost immediately after the infusion stops, which is ideal for brief procedures where you need deep analgesia during the event but want full recovery right after. Because of this, its best use is for short, painful procedures that require transient profound analgesia, such as during laryngoscopy or when performing blocks that benefit from rapid onset and offset—like retrobulbar injections for eye surgery. It’s not suited for chronic cancer pain management, since it requires continuous IV administration for ongoing relief and cannot provide sustained long-term analgesia. It’s also not given orally and isn’t practical for long-term postoperative analgesia, as the effect ends quickly once the infusion stops, necessitating continuous high-dose IV infusions for any extended use.

Remifentanil is an ultra-short-acting opioid that is rapidly metabolized by plasma esterases, giving a very quick onset and a context-insensitive half-life of only a few minutes. This means its analgesic effects (and any sedation) disappear almost immediately after the infusion stops, which is ideal for brief procedures where you need deep analgesia during the event but want full recovery right after.

Because of this, its best use is for short, painful procedures that require transient profound analgesia, such as during laryngoscopy or when performing blocks that benefit from rapid onset and offset—like retrobulbar injections for eye surgery. It’s not suited for chronic cancer pain management, since it requires continuous IV administration for ongoing relief and cannot provide sustained long-term analgesia. It’s also not given orally and isn’t practical for long-term postoperative analgesia, as the effect ends quickly once the infusion stops, necessitating continuous high-dose IV infusions for any extended use.